Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index falling 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.8%.
The iShares Biotechnology ETF (IBB) was shedding 0.5%.
In corporate news, Eli Lilly (LLY) expanded its collaboration with Resilience to invest $750 million as part of its effort to boost US production of Lilly's KwikPen injectable device for diabetes and obesity medicines, Resilience said Thursday. Lilly shares were down 3.9%.